Histopathology and tumor biomarker analysis confirm cel-sci's multikine significantly prolonged overall survival in head & neck cancer—phase 3 data presented at estro 2023

Vienna, va.--(business wire)---- $cvm #estro23--histopathology and tumor biomarker analysis confirm cel-sci's multikine significantly prolonged overall survival in head & neck cancer.
CVM Ratings Summary
CVM Quant Ranking